These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25558401)

  • 21. Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha-bungarotoxin-treated rats.
    Plomp JJ; van Kempen GT; Molenaar PC
    J Physiol; 1992 Dec; 458():487-99. PubMed ID: 1302275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of N-acetylaspartylglutamate (NAAG) on non-quantal and spontaneous quantal release of acetylcholine at the neuromuscular synapse of rat.
    Malomouzh AI; Nikolsky EE; Lieberman EM; Sherman JA; Lubischer JL; Grossfeld RM; Urazaev AKh
    J Neurochem; 2005 Jul; 94(1):257-67. PubMed ID: 15953368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscarinic inhibition of quantal transmitter release from the magnesium-paralysed frog sartorius muscle.
    Arenson MS
    Neuroscience; 1989; 30(3):827-36. PubMed ID: 2788830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute in vivo exposure to ethylcholine aziridinium (AF64A) depresses the secretion of quanta from motor nerve terminals.
    McArdle JJ; Hanin I
    Eur J Pharmacol; 1986 Nov; 131(1):119-21. PubMed ID: 3816942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.
    Plomp JJ; van Kempen GT; Molenaar PC
    J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):125-36. PubMed ID: 7965828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylcholine release at identified nerve terminals in the organ-cultured frog neuromuscular preparation.
    Cherki-Vakil R; Meiri H
    J Physiol; 1990 Apr; 423():579-92. PubMed ID: 2167368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional coupling of Ca(2+) channels to ryanodine receptors at presynaptic terminals. Amplification of exocytosis and plasticity.
    Narita K; Akita T; Hachisuka J; Huang S; Ochi K; Kuba K
    J Gen Physiol; 2000 Apr; 115(4):519-32. PubMed ID: 10736317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tetrandrine on spontaneous and evoked release of acetylcholine at the mouse neuromuscular junction.
    Wiegand H; McIntosh LJ; Gotzsch U; Krämer U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):891-901. PubMed ID: 8930197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha7-nicotinic acetylcholine receptors on cerebral perivascular sympathetic nerves mediate choline-induced nitrergic neurogenic vasodilation.
    Si ML; Lee TJ
    Circ Res; 2002 Jul; 91(1):62-9. PubMed ID: 12114323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P2X(7) receptors exert a permissive role on the activation of release-enhancing presynaptic alpha7 nicotinic receptors co-existing on rat neocortex glutamatergic terminals.
    Patti L; Raiteri L; Grilli M; Parodi M; Raiteri M; Marchi M
    Neuropharmacology; 2006 May; 50(6):705-13. PubMed ID: 16427662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing quantal size at the mouse neuromuscular junction and the role of choline.
    Yu SP; Van der Kloot W
    J Physiol; 1991 Feb; 433():677-704. PubMed ID: 1841963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine induces calcium spikes in single nerve terminal varicosities: a role for intracellular calcium stores.
    Brain KL; Trout SJ; Jackson VM; Dass N; Cunnane TC
    Neuroscience; 2001; 106(2):395-403. PubMed ID: 11566509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synaptic potentials mediated by alpha 7 nicotinic acetylcholine receptors in supraoptic nucleus.
    Hatton GI; Yang QZ
    J Neurosci; 2002 Jan; 22(1):29-37. PubMed ID: 11756485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Bay K 8644 on spontaneous and evoked transmitter release at the mouse neuromuscular junction.
    Pancrazio JJ; Viglione MP; Kim YI
    Neuroscience; 1989; 30(1):215-21. PubMed ID: 2473411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals.
    Tian L; Prior C; Dempster J; Marshall IG
    J Physiol; 1994 May; 476(3):517-29. PubMed ID: 7914535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices.
    Alkondon M; Pereira EF; Eisenberg HM; Albuquerque EX
    J Neurosci; 1999 Apr; 19(7):2693-705. PubMed ID: 10087082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of single quantal efficacy at the snake neuromuscular junction.
    Wilkinson RS; Lunin SD; Stevermer JJ
    J Physiol; 1992 Mar; 448():413-36. PubMed ID: 1350638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of protein kinases in the upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats.
    Plomp JJ; Molenaar PC
    J Physiol; 1996 May; 493 ( Pt 1)(Pt 1):175-86. PubMed ID: 8735703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.